Search
for
Sort by
Research 30 of 1000+
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- The JAK/STAT signaling pathway: from bench to clinic
- JAK inhibitors in dermatology: The promise of a new drug class
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Janus kinase inhibitors in dermatology: A systematic review
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- A Review (Research and Patents) on Jasmonic Acid and Its Derivatives
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- JAK Inhibitors for Treatment of Alopecia Areata
- Topical Janus kinase inhibitors: A review of applications in dermatology
- Cortical cell types and intermediate filament arrangements correlate with fiber curvature in Japanese human hair
- WNT5A drives interleukin-6-dependent epithelial–mesenchymal transition via the JAK/STAT pathway in keloid pathogenesis
- JAK inhibitors and alopecia areata
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- JAW WIRING IN TREATMENT OF OBESITY
- Inhibiting Janus kinases to treat alopecia areata
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients